SmiLe is a full range Life Science Incubator hosting companies from Biomedicine to E-Health and providing pharma development labs and business support. Since start 2008, SmiLe has supported over 60 companies whereof 14 have achieved successful IPOs. In the last four years, our community of startups has attracted over 210 MEURO in venture capital. We see continued success ahead. This is your portal to SmiLe news.
Sign up for SmiLe Insights
SmiLe Insights is a brand new financial and industry newsletter presenting current startup portfolio, news, presentations and coming opportunities from our community. SmiLe startups have consistently achieved growth and success through strong investors and valuable partnerships. Looking forward to continued positive results and a greater community, this publication provides broader access to new startups, companies’ progress, and to financial, licensing and transactional opportunities.
If you are interested in SmiLe news and want to receive the newsletter, please subscribe for SmiLe Insights.
You can also read our recent newsletter online:
Newsletter October 2018
Newsletter July 2018
Newsletter April 2018
Investment opportunities
This list does not cover all issues but highlights some opportunities. The figures are assumptions based on the companies forecasted needs. The final offers will be presented by the companies at launch of their financing efforts.
Receptor Pharma AB
Seeking first 500 000 SEK now, for initial discovery in Alzheimers
www.receptorpharma.com
POOW AB
Seeking seed funding for global expansion of a super hero app for eating disorders
www.poowapplications.se / See one-pager
Medotemic AB
Seeking seed funding for market launch of a motion analysis app for rehabilitation
www.medotemic.se / See one-pager
Speximo AB
Seeking funding for industrial scale up of emulsions for skin products
www.speximo.com
Acrivon AB
Currently raising $25M Series A to advance 2 lead programs to the clinic in 2 years, and anticipate 2 clinical POC within 4 years. Acrivon is an oncology and fibrosis company specialized in accelerated drug development using a unique, predictive biomarker approach.
www.acrivon.com / See one-pager
TigerQ AB
Seeking seed funding for development and launch of an automated service for NGS-based genome editing quantification.
www.tigerq.com / See one-pager
Sinntaxis AB
Seeking funding for pre-clinical phase drug development for recovery of brain function after stroke
www.sinntaxis.com / See one-pager
MedVasc AB
Seeking funding
www.medvasc.se / See one-pager
Cellevate AB
Seeking funding
www.cellevate.com / See one-pager
SmiLe Portfolio
Recent news
Sign up for SmiLe´s newsletter to receive information about our incubator companies